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E-mail address: masanori@yamanashi.ac.jp (M. KitProteasome inhibitor MG132 blocks activation of NF-jB by preventing degradation of IjB. In this
report, we propose an alternative mechanism by which MG132 inhibits cytokine-triggered NF-jB
activation. We found that MG132 induced endoplasmic reticulum (ER) stress, and attenuation of
ER stress blunted the suppressive effect of MG132 on NF-jB. Through ER stress, MG132 up-regulated
C/EBPbmRNA transiently and caused sustained accumulation of its translational products liver acti-
vating protein (LAP) and liver-enriched inhibitory protein (LIP), both of which were identiﬁed as
suppressors of NF-jB. Our results disclosed a novel mechanism underlying inhibition of NF-jB by
MG132.
 2011 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
MG132 is a proteasome inhibitor with the potential to inhibit
nuclear factor-jB (NF-jB). It is well known that MG132 blocks
activation of NF-jB through preventing proteasome-mediated deg-
radation of IjB, an endogenous inhibitor of NF-jB [1]. MG132 is
also known as an inducer of endoplasmic reticulum (ER) stress. Be-
cause unfolded and misfolded proteins are degraded by the protea-
some system [2], treatment with MG132 results in accumulation of
immature proteins in the ER, leading to ER stress. Indeed, previous
reports showed that MG132 induced expression of 78 kDa glucose-
regulated protein (GRP78) and CCAAT/enhancer-binding protein
homologous protein (CHOP), the indicators for ER stress [3,4]. Cur-
rently, however, relationship between induction of ER stress and
inhibition of NF-jB by MG132 is unknown.
CCAAT/enhancer-binding protein (C/EBP) is a family of tran-
scription factors that possess a highly conserved, basic leucine-zip-
per (bZIP) domain required for their dimerization and DNA
binding. There are six members in the C/EBP family; C/EBPa, b, d,
c, e and f [5]. In particular, C/EBPb is stress-inducible and plays
signiﬁcant roles in cell proliferation, differentiation, metabolism
and inﬂammatory responses [5]. C/EBPb is produced from C/EBPb
mRNA as three distinct protein isoforms, i.e., 38 kDa liver activat-
ing protein 1 (LAP1), 35 kDa LAP2 and 20 kDa liver-enriched
inhibitory protein (LIP). LAP functions as a transcriptional activa-
tor, whereas LIP acts as a dominant-negative inhibitor of LAP [6].chemical Societies. Published by E
amura).A previous report indicated that the human C/EBPb gene has an un-
folded protein response element (UPRE) at the 30 end, which may
cause induction of C/EBPb by ER stress [7]. It is known that, via
the bZIP domain, C/EBPs physically interact with the Rel homology
domain of NF-jB [8]. Prösch et al. reported that C/EBPa/b inter-
acted with NF-jB p65 subunit and inhibited activation of NF-jB
[9]. Based on these previous ﬁndings, we hypothesized that ER
stress-mediated induction of C/EBPb could be involved in the sup-
pression of NF-jB by MG132. The present investigation was per-
formed to examine this possibility.
2. Materials and methods
2.1. Reagents
MG132 was purchased from Peptide Institute (Osaka, Japan). A
concentration 5 lM was generally used for experiments, unless
indicated otherwise. Thapsigargin, tunicamycin and cycloheximide
were obtained from Sigma–Aldrich Japan (Tokyo, Japan). Human
recombinant TNF-a was purchased from R&D Systems (Minneapo-
lis, MN), and 4-phenylbutyrate (4-PBA) was from Calbiochem (San
Diego, CA). Subtilase cytotoxin (SubAB) was kindly provided by Dr.
James C. Paton (University of Adelaide, South Australia, Australia)
[10].
2.2. Cells and stable transfectants
The rat renal tubular epithelial cell line NRK-52E was purchased
from American Type Culture Collection (Manassas, VA). Usinglsevier B.V. All rights reserved.
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pNFjB-Luc (Panomics; Fremont, CA) that introduces a luciferase
gene under the control of the jB site, and NRK/NFjB-Luc cells were
established. Mock-transfected NRK/Neo cells and NRK/ORP150
cells that constitutively express 150 kDa oxygen-regulated protein
(ORP150) were established using pcDNA3.1 (Invitrogen; Carlsbad,
CA) andpCI-neo-ORP150 (provided byDr. Satoshi Ogawa; Kanazawa
University, Kanazawa, Japan) [11], respectively. NRK/siControl
cells and NRK/siC/EBPb cells were established using pRNA-U6.1-
Neo (GenScript; Piscataway, NJ) and pRNA-U6.1-siC/EBPb that
introduces rat C/EBPb siRNA, as described previously [12]. Experi-
ments were performed in the presence of 1% fetal bovine serum
(FBS).
2.3. Transient transfection
NRK-52E cells were transiently transfected with pNFjB-Luc,
pCMV4-p65 (Addgene; Cambridge, MA), pCAX-F-XBP1DDBD-Luc
(provided by Dr. Takao Iwawaki; RIKEN, Wako, Japan) [13],
pUPRE-Luc (provided by Dr. Laurie H. Glimcher; Harvard Medical
School, Boston, MA) [14], pcDNA-LAP or pcDNA-LIP (Provided by
Dr. Jacob Friedman; University of Colorado, Denver, CO) [15]. After
48 h, the cells were treated with test reagents and subjected to
luciferase assay.
2.4. Luciferase assay
Activity of luciferase was evaluated by Luciferase Assay System
(Promega; Madison, WI) according to the manufacturer’s protocol.
2.5. Northern blot analysis
Total RNA was extracted by a single-step method, and Northern
blot analysis was performed as described before [16]. cDNAs for C/
EBPb (provided by Dr. Ez-Zoubir Amri; CNRS, Nice, France) [17],
monocyte chemoattractant protein 1 (MCP-1) [18], GRP78 (pro-
vided by Dr. Kazunori Imaizumi; University of Miyazaki, Miyazaki,
Japan) [19], CHOP [20], activating transcription factor 4 (ATF4)
(provided by Dr. David Ron; New York University School of Medi-
cine, New York, NY) and ORP150 (provided by Dr. Satoshi Ogawa)
[11] were used to prepare radio-labeled probes. Expression of glyc-
eraldehyde-3-phosphate dehydrogenase (GAPDH) was used as a
loading control.
2.6. Western blot analysis
Western blot analysis was performed by the enhanced chemilu-
minescence system (Amersham Biosciences; Buckinghamshire,
UK), as described previously [21]. Primary antibodies used were:
anti-phospho-eIF2a (Ser51) antibody and anti-eIF2a antibody
from Cell Signaling Technology (Beverly, MA), anti-IjBa antibody,
anti-C/EBPb antibody, anti-GADD153 (CHOP) antibody and anti-
p65 antibody from Santa Cruz Biotechnology (Santa Cruz, CA). As
a loading control, levels of b-actin were evaluated using anti-b-
actin antibody (Sigma–Aldrich Japan).
2.7. Formazan assay
The number of viable cells was assessed by a formazan assay
using Cell Counting Kit-8 (Dojindo Laboratory; Kumamoto, Japan).
2.8. Statistical analysis
In reporter assays and the formazan assay, experiments were
performed in quadruplicate, and data were expressed as mean-
s ± S.E. Statistical analysis was performed using the non-parametricMann–WhitneyU-test to compare data in different groups. A P value
<0.05 was considered to indicate a statistically signiﬁcant
difference.3. Results
3.1. Inhibition of cytokine-triggered NF-jB activation by MG132
We ﬁrst examined an effect of MG132 on the activation of NF-
jB by TNF-a in NRK-52E cells. NRK/NFjB-Luc cells were treated
with MG132 for 6 h, exposed to TNF-a and subjected to luciferase
assay to evaluate activity of NF-jB. Reporter assay showed that
MG132 markedly inhibited activation of NF-jB by TNF-a
(Fig. 1A). It was correlated with blunted expression of MCP-1, a
NF-jB-dependent chemokine (Fig. 1B). As expected, treatment
with MG132 inhibited TNF-a-triggered degradation of IjBa
(Fig. 1C). However, unexpectedly, activation of NF-jB by overex-
pression of p65 was also suppressed by MG132 (Fig. 1D), suggest-
ing another target of MG132 to inhibit NF-jB downstream of IjB
degradation. It is known that IjBa is a NF-jB-dependent gene
[22]. Indeed, overexpression of p65 caused up-regulation of IjBa
protein. Even in this experimental situation, treatment with
MG132 down-regulated the level of IjBa (Supplementary
Fig. S1), further supporting our idea that MG132 also suppresses
activation of NF-jB downstream of IjB.
3.2. Induction of ER stress and the unfolded protein response (UPR) by
MG132
Proteasome inhibition is known to cause ER stress [23]. We next
examined whether MG132 has the potential to induce ER stress
and consequent UPR in NRK-52E cells. Cells were treated with
MG132 for different time periods and subjected to Northern blot
analysis. MG132 rapidly induced expression of ER stress markers
GRP78, CHOP and ATF4, and it was sustained for at least 12 h
(Fig. 2A). MG132 also induced phosphorylation of eukaryotic trans-
lation initiation factor 2a (eIF2a) (Fig. 2B), splicing of X-box-bind-
ing protein 1 (XBP1) mRNA (Fig. 2C) and downstream activation of
the UPRE (Fig. 2D). These results evidenced that MG132 caused
induction of ER stress and consequent UPR in NRK-52E cells.
3.3. Involvement of ER stress in the suppressive effect of MG132 on NF-
jB
To examine involvement of ER stress in the suppressive effect of
MG132 on NF-jB, kinetics of a NF-jB indicator and ER stress mark-
ers was evaluated in parallel. As shown in Fig. 3A, TNF-a induced
expression ofMCP-1, and it was inhibited by MG132. The inhibition
ofMCP-1was inversely correlated with up-regulation of CHOP. Like
MG132, other ER stress inducers thapsigargin and tunicamycin
also suppressedMCP-1, which was inversely correlated with induc-
tion of ER stress markers (Fig. 3B). To test whether ER stress is
responsible for the suppression of NF-jB by MG132, cells were sta-
bly transfected with ORP150, an ER chaperone, and ER stress-resis-
tant NRK/ORP150 cells were created. The established cells
expressed ORP150 abundantly (Fig. 3C, middle row), and it was cor-
related with blunted phosphorylation of eIF2a and attenuated
induction of CHOP in response to MG132 (Supplementary
Fig. S2A and B). Mock-transfected NRK/Neo cells and NRK/
ORP150 cells were then stimulated by TNF-a in the absence or
presence of MG132, and expression levels of MCP-1 were evalu-
ated. Compared with NRK/Neo cells, NRK/ORP150 cells exhibited
resistance to the suppressive effect of MG132 on MCP-1 (Fig. 3C,
top row). To further conﬁrm our conclusion, NRK-52E cells were
treated with MG132 in the absence or presence of chemical
Fig. 1. Inhibition of TNF-a-triggered activation of NF-jB by MG132. (A) NRK/NFjB-Luc cells were treated with or without 5 lMMG132 for 6 h, exposed to 10 ng/ml TNF-a for
6 h and subjected to luciferase assay. Activity of luciferase was normalized by the number of viable cells estimated by formazan assay, and relative values (%) are shown.
Assay were performed in quadruplicate, and data are presented as means ± S.E. Statistical analysis was performed using the non-parametric Mann–Whitney U-test to
compare data in different groups. An asterisk indicates a statistically signiﬁcant difference (P < 0.05). (B) NRK-52E cells were pretreated with or without MG132 for 6 h,
exposed to TNF-a for additional 6 h and subjected to Northern blot analysis ofMCP-1. Expression of GAPDH is shown at the bottom as a loading control. (C) Cells were treated
with or without MG132 for 12 h, exposed to TNF-a for up to 60 min and subjected to Western blot analysis of IjBa. The level of b-actin is shown at the bottom as a loading
control. (D) Cells were co-transfected with empty vector () or p65 NF-jB subunit (+) together with pNFjB-Luc. Cells were then treated with MG132 for 12 h and subjected to
luciferase assay to evaluate NF-jB activity.
Fig. 2. Induction of ER stress and consequent UPR by MG132. (A) Cells were treated
with MG132 for indicated time periods, and expression of GRP78, CHOP and ATF4
was examined by Northern blot analysis. (B) Cells were treated with MG132 for up
to 3 h and subjected to Western blot analysis of phosphorylated eIF2a and total
eIF2a protein. (C, D) Cells were transiently transfected with pCAX-F-XBP1DDBD-
Luc (C) or pUPRE-Luc (D), treated with MG132 for 12 h and subjected to luciferase
assay.
Fig. 3. Involvement of ER stress in the suppressive effect of MG132 on NF-jB. (A)
Cells were treated with MG132 for 6 h, exposed to TNF-a for 6 h and subjected to
Northern blot analysis. (B) Cells were treated with 500 nM thapsigargin (Tg) or
1 lg/ml tunicamycin (Tm) for 6 h, exposed to TNF-a and subjected to Northern blot
analysis. (C) NRK/Neo cells and NRK/ORP150 cells were treated with or without
MG132 for 6 h, stimulated by TNF-a and subjected to Northern blot analysis of
MCP-1 and ORP150. (D) NRK-52E cells were transiently transfected with pNFjB-Luc.
Cells were then treated with 300 nM MG132 in the absence or presence of 5 mM 4-
PBA for 6 h, exposed to TNF-a and subjected to analysis.
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used a lower concentration of MG132 (300 nM) that causes the
UPR and modest inhibition of NF-jB (50% inhibition). It is be-
cause 5 lMMG132 strongly inhibits NF-jB (Fig. 1A), and the rever-
sal effect of 4-PBA may be only small because of complete
inhibition of IjB degradation. Induction of ER stress by 300 nM
MG132 and its suppression by 4-PBA were conﬁrmed by Western
blot analysis of phosphorylated eIF2a and CHOP (SupplementaryFig. S3). As shown in Fig. 3D, the inhibitory effect of MG132 on
NF-jB was blunted in the presence of 4-PBA. These results suggest
involvement of ER stress in the suppressive effect of MG132 on
NF-jB activation.
Fig. 4. Involvement of C/EBPb in the suppression of NF-jB by MG132. (A) Cells were treated with MG132 for up to 12 h, and expression of C/EBPbwas examined by Northern
blot analysis. (B, C) Cells were treated with MG132 (B) or 10 ng/ml SubAB (C) for indicated time periods and subjected to Western blot analysis of LAP and LIP. (D) Cells were
treated with MG132 in the absence or presence of 4-PBA for 12 h, and Western blot analysis was performed. (E) Cells were transiently co-transfected with empty vector
(control), pcDNA-LAP, pcDNA-LIP or in combination together with pNFjB-Luc. The cells were then treated with or without TNF-a and subjected to luciferase assay. (F) NRK/
siControl cells and NRK/siC/EBPb cells were treated with or without MG132 for 12 h and subjected to Western blot analysis. (G) NRK/siControl cells and NRK/siC/EBPb cells
were treated with or without MG132 for 6 h, exposed to TNF-a and subjected to Northern blot analysis ofMCP-1. (H) Cells were transiently co-transfected with siControl ()
or siC/EBPb (+) together with pNFjB-Luc, treated with 500 nM MG132 for 6 h, exposed to TNF-a and subjected to luciferase assay.
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NF-jB by MG132
To identify molecular mechanisms involved, we focused on a
role of C/EBPb. First, we examined whether or not MG132 induces
expression of C/EBPb mRNA. Northern blot analysis showed that
MG132 transiently induced expression of C/EBPb with a peak at
3 h (Fig. 4A). It is known that C/EBPb mRNA is translated into dis-
tinct isoforms; 38/35 kDa LAP1/2 and 20 kDa LIP. Western blot
analysis showed that LAP1/2 and LIP proteins were up-regulated
by MG132, which was sustained for at least 12 h (Fig. 4B). The
induction of LAP and LIP was through ER stress, because; (1) Sub-
AB, a selective UPR inducer [24], reproduced the effect of MG132
(Fig. 4C), and (2) the chemical chaperone 4-PBA attenuated induc-
tion of LAP and LIP by MG132 (Fig. 4D).
To examine involvement of C/EBPb in the suppression of NF-jB
byMG132, cellswere transiently co-transfectedwith pNFjB-Luc to-
gether with pcDNA-LAP, pcDNA-LIP or in combination and exposed
to TNF-a. Reporter assay showed that overexpression of LAP or LIP
signiﬁcantly suppressed activation of NF-jB by TNF-a. Combina-
tional transfection further reinforced the suppressive effect of LAP
or LIP alone (Fig. 4E). To further conﬁrm this result, we establishedNRK/siC/EBPb cells stably expressing C/EBPb siRNA. NRK/siC/EBPb
cells exhibited blunted induction of LAP and LIP in response to
MG132 (Fig. 4F). In the established C/EBPb-knockdown cells, the
suppressive effect of MG132 on TNF-a-induced MCP-1 expression
was attenuated (Fig. 4G). Consistent with this result, reporter assay
also showed that knockdown of C/EBPb reversed the suppressive ef-
fect ofMG132 on NF-jB (Fig. 4H). Taken together, these results sug-
gest that MG132 inhibits activation of NF-jB through the UPR-
mediated up-regulation of C/EBPb, i.e., LAP and LIP.
4. Discussion
MG132, the proteasome inhibitor, is believed to interfere with
activation of NF-jB via blockade of IjB degradation. In the present
report, however, we propose another mechanism underlying the
inhibitory effect of MG132 on NF-jB. We found that inhibition of
the NF-jB pathway occurred not only at the IjB level but also at
a level downstream of IjB. We identiﬁed that LAP and LIP were
possible candidates that mediate the suppressive effect of MG132
on NF-jB. To our knowledge, this is the ﬁrst report to demonstrate;
(i) MG132-induced UPR cause induction of C/EBPb, both LAP and
LIP, (ii) LAP and LIP suppress activation of NF-jB by TNF-a, and
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scriptional induction and, possibly, post-translational stabilization.
Our current results showed that overexpression of LAP and LIP
suppressed activation of NF-jB. In contrast to LAP, LIP lacks the
transactivation domain. Because of this reason, LIP inhibits LAP-
mediated transcription in a dominant-negative fashion [6]. The fact
that both LAP and LIP had the similar inhibitory effect suggests that
the suppressive effect of C/EBPb on NF-jB is independent of its
transacting potential. It may be ascribed to direct, physical interac-
tion between the bZIP region of C/EBP and the Rel homology do-
main of NF-jB [8]. Prösch et al. reported that C/EBPa/b
interacted with NF-jB p65 subunit and inhibited activation of
NF-jB [9]. Another report also showed that, in TNF-tolerant mono-
cytic cells, C/EBPb speciﬁcally prevented p65 phosphorylation and
blocked NF-jB activation [25]. The similar mechanism may under-
lie inhibition of the NF-jB pathway by MG132 downstream of IjB.
In the present report, we demonstrated that MG132 induced
expression of C/EBPb mRNA (Fig. 4A). However, the expression of
C/EBPb was only transient with a peak at 3 h. In contrast, up-regu-
lation of C/EBPb protein by MG132 was sustained for at least 12 h.
This result raises a possibility that the increase in C/EBPb protein in
the later phase may be caused by inhibition of protein degradation.
Indeed, our preliminary result showed that degradation of C/EBPb
was attenuated by the treatment with MG132 (Supplementary
Fig. S4), supporting this possibility.
In the present investigation, we elucidated that MG132 induces
ER stress that contributes to the suppressive effect of MG132 on
NF-jB. We identiﬁed that induction of C/EBPb is a mechanism
underlying this inhibitory effect. However, ER stress may contrib-
ute to the suppression of NF-jB in other ways. For example, we
previously reported that ER stress inducers including tunicamycin,
thapsigargin and SubAB suppressed TNF-a-induced degradation of
IjBa [12,21]. Thus, ER stress triggered by MG132 may interfere
with the TNF-a signaling at multiple sites – not only downstream
but also upstream of IjB. Further investigation will be required to
ﬁgure out the entire scheme of the NF-jB inhibition by MG132 via
the UPR.
In summary, MG132 inhibits NF-jB through blockade of protea-
some-mediated degradation of IjB. In addition to this effect, our
present ﬁndings elucidated another underlying mechanism. That
is, MG132 can inhibit NF-jB, at least in part, through ER stress-
mediated up-regulation of C/EBPb. Because degradation of IjBa
is very quick following exposure to TNF-a, it is reasonable to spec-
ulate that, in the early phase, MG132 inhibits activation of NF-jB
via suppression of proteasome-mediated IjB degradation. In the
later phase, however, induced C/EBPb also contributes to the sup-
pression of NF-jB at a distinct step. The fact that knockdown of
C/EBPb substantially reduced the suppressive effect of MG132 on
NF-jB (Fig. 4H) supports this possibility. The dual blockade of
the NF-jB pathway may underlie the strong anti-inﬂammatory po-
tential of MG132 in vivo [26,27].
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